Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

NCT: NCT05591118 · RECRUITING

NCT IDNCT05591118
StatusRECRUITING
Start Date2023-07-17
Completion2027-08-04

Brief Summary

PE-TRACT is an open-label, assessor-blinded, randomized trial, aiming to compare catheter-directed therapy (CDT) and anticoagulation (CDT group) with anticoagulation alone (No-CDT) in 500 patients with submassive PE, proximal pulmonary artery thrombus and right ventricular dilation.

Frequently Asked Questions

What is Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy?

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy is a clinical trial registered under NCT05591118. Current status: RECRUITING.

What is the status of NCT05591118?

The current status of NCT05591118 (Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy) is: RECRUITING.

When did Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy start?

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy started on 2023-07-17.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑